On Jan. 11, President Donald Trump announced via Twitter that 2018 was marked by a decline in prescription drug prices – the first time that had happened in 50 years. Also, the president said that Americans saved $26 billion on drug prices in the first 19 months of his presidency. Trump ended his tweet by stating that his administration’s policies to get cheaper generic drugs to the market are working. All of this was announced while pharmaceutical companies that serve the U.S. marke...
READ MORE
|
Memorial Sloan Kettering Cancer Center Chief Medical Officer José Baselga, who resigned from the cancer center in September under a cloud, has been tapped as the new head of oncology research and discovery at AstraZeneca. In the company’s announcement this morning, AstraZeneca Chief Executive Officer Pascal Soriot called Baselga am “outstanding scientific leader in oncology.” He said that Baselga’s research and clinical achievements “have led to the developme...
READ MORE
|
The Financial Times has reported that the Brexit secretary doesn’t accept that the European drugs regulator and its 900 staff need to depart from London when the UK exits the European Union – despite Europe’s leaders indicating that this would be impossible....
READ MORE
|
Marathon Pharmaceuticals’ approval, last week, by the FDA for its treatment for Duchenne muscular dystrophy would usually have been cause for celebration within the pharmaceutical company and more than likely it was – but only for the weekend. Starting on Monday morning, the price of the treatment started hitting the headlines and suddenly Marathon was experiencing a hangover to the party rather than sooner than they would have hoped....
READ MORE
|
Accelerating access to pancreatic surgery has been shown to boost success rates by more than a fifth with a cost saving to the NHS of around £3,200 per patient. A pilot treatment pathway for pancreatic cancer, funded by Pancreatic Cancer UK and held at University Hospitals Birmingham NHS Foundation Trust, slashed the average time to surgery from two months to just over two weeks. Referrals for patients were sped up and the way surgery was carried out was reorganised, while the team also cut out ...
READ MORE
|
A new study from the University of Georgia pinpoints lifestyle factors that could lead to hardened arteries. One of the largest of its kind, the study performed an untargeted metabolomics profile of over 1,200 participants of the Bogalusa Heart Study to identify metabolites linked to the hardening of arteries. Hardening arteries, or arterial stiffness, is an independent risk factor for heart disease and death, and the mechanisms that contribute to arterial stiffening are not well understood. Tha...
READ MORE
|